|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 September 2000, Vol. 96, No. 6, pp. 2172-2180
IMMUNOBIOLOGY
Role of common cytokine receptor chain ( c)-
and Jak3-dependent signaling in the proliferation and survival of
murine mast cells
Kotaro Suzuki,
Hiroshi Nakajima,
Norihiko Watanabe,
Shin-ichiro Kagami,
Akira Suto,
Yasushi Saito,
Takashi Saito, and
Itsuo Iwamoto
From the Department of Internal Medicine II, Chiba
University School of Medicine, Chiba; and Department of Molecular
Genetics, Chiba University Graduate School of Medicine, Chiba, Japan.
The regulatory roles of the common cytokine receptor chain
( c)- and Jak3-dependent signaling in the proliferation
and survival of mast cells were determined using
c-deficient ( c ) and
Jak3-deficient (Jak3 ) mice. Although the mast cells in
c and Jak3 mice were
morphologically indistinguishable from those in wild-type mice, the
number of peritoneal mast cells was decreased in
c and Jak3 mice as compared
with that in wild-type mice. Among c-related cytokines,
interleukin (IL)-4 and IL-9, but not IL-2, IL-7, or IL-15, enhanced the
proliferation and survival of bone marrow-derived mast cells (BMMCs)
from wild-type mice. However, the effects of IL-4 and IL-9 were absent
in BMMCs from c and Jak3
mice. In addition, IL-4R , c, and Jak3, but not
IL-2R or IL-7R , were expressed in BMMCs. In contrast, IL-13 did
not significantly induce the proliferation and survival of BMMCs even
from wild-type mice, and IL-13R 1 was not expressed in BMMCs.
Furthermore, IL-4 phosphorylated the 65-kd isoform of Stat6 in BMMCs
from wild-type mice but not from c and
Jak3 mice. These results indicate that c-
and Jak3-dependent signaling is essential for IL-4- and IL-9-induced
proliferation and survival of murine mast cells, that the effects of
IL-4 are mediated by type I IL-4R and that type II IL-4R is absent on
mast cells, and that IL-4 phosphorylates the 65-kd isoform of Stat6 in
mast cells in a c- and Jak3-dependent manner.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. G. Jones, J. Hallgren, A. Humbles, T. Burwell, F. D. Finkelman, P. Alcaide, K. F. Austen, and M. F. Gurish
Antigen-Induced Increases in Pulmonary Mast Cell Progenitor Numbers Depend on IL-9 and CD1d-Restricted NKT Cells
J. Immunol.,
October 15, 2009;
183(8):
5251 - 5260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Waskow, S. Bartels, S. M. Schlenner, C. Costa, and H.-R. Rodewald
Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin
Blood,
June 15, 2007;
109(12):
5363 - 5370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Loesch, L. Deng, J. W. Cowan, X. Wang, K. He, J. Jiang, R. A. Black, and S. J. Frank
Janus Kinase 2 Influences Growth Hormone Receptor Metalloproteolysis
Endocrinology,
June 1, 2006;
147(6):
2839 - 2849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. He, K. Loesch, J. W. Cowan, X. Li, L. Deng, X. Wang, J. Jiang, and S. J. Frank
Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor
Endocrinology,
November 1, 2005;
146(11):
4755 - 4765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lorentz, M. Wilke, G. Sellge, H. Worthmann, J. Klempnauer, M. P. Manns, and S. C. Bischoff
IL-4-Induced Priming of Human Intestinal Mast Cells for Enhanced Survival and Th2 Cytokine Generation Is Reversible and Associated with Increased Activity of ERK1/2 and c-Fos
J. Immunol.,
June 1, 2005;
174(11):
6751 - 6756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kohno, S. Yamasaki, V. L. J. Tybulewicz, and T. Saito
Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen
Blood,
March 1, 2005;
105(5):
2059 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ikeda, H. Nakajima, K. Suzuki, S.-i. Kagami, K. Hirose, A. Suto, Y. Saito, and I. Iwamoto
Mast cells produce interleukin-25 upon Fcepsilon RI-mediated activation
Blood,
May 1, 2003;
101(9):
3594 - 3596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Migliaccio, R. A. Rana, M. Sanchez, R. Lorenzini, L. Centurione, L. Bianchi, A. M. Vannucchi, G. Migliaccio, and S. H. Orkin
GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1low Mouse Mutant
J. Exp. Med.,
February 3, 2003;
197(3):
281 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Madden, L. Whitman, C. Sullivan, W. C. Gause, J. F. Urban Jr., I. M. Katona, F. D. Finkelman, and T. Shea-Donohue
Role of STAT6 and Mast Cells in IL-4- and IL-13-Induced Alterations in Murine Intestinal Epithelial Cell Function
J. Immunol.,
October 15, 2002;
169(8):
4417 - 4422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sherman, D. R. Powell, and M. A. Brown
IL-4 Induces the Proteolytic Processing of Mast Cell STAT6
J. Immunol.,
October 1, 2002;
169(7):
3811 - 3818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, H. Nakajima, S.-i. Kagami, A. Suto, K. Ikeda, K. Hirose, T. Hiwasa, K. Takeda, Y. Saito, S. Akira, et al.
Proteolytic Processing of Stat6 Signaling in Mast Cells as a Negative Regulatory Mechanism
J. Exp. Med.,
July 1, 2002;
196(1):
27 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Malaviya and F. M. Uckun
Role of STAT6 in IgE Receptor/Fc{varepsilon}RI-Mediated Late Phase Allergic Responses of Mast Cells
J. Immunol.,
January 1, 2002;
168(1):
421 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Urban Jr., N. Noben-Trauth, L. Schopf, K. B. Madden, and F. D. Finkelman
Cutting Edge: IL-4 Receptor Expression by Non-Bone Marrow-Derived Cells Is Required to Expel Gastrointestinal Nematode Parasites
J. Immunol.,
December 1, 2001;
167(11):
6078 - 6081.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|